Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Oct 14, 2020
Open Peer Review Period: Apr 28, 2021 - Jun 28, 2021
Date Accepted: Feb 2, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Web-Based Patient Educational Material on Osteosarcoma: Quantitative Assessment of Readability and Understandability

Gulbrandsen T, Skalitzky MK, Shamrock AG, Gao B, Hasan O, Miller BJ

Web-Based Patient Educational Material on Osteosarcoma: Quantitative Assessment of Readability and Understandability

JMIR Cancer 2022;8(1):e25005

DOI: 10.2196/25005

PMID: 35323117

PMCID: 8990380

Osteosarcoma Online Resources: A Quantitative Assessment of the Understandability and Readability of Web-based Patient Education Material

  • Trevor Gulbrandsen; 
  • Mary Kate Skalitzky; 
  • Alan Gregory Shamrock; 
  • Burke Gao; 
  • Obada Hasan; 
  • Benjamin James Miller

ABSTRACT

Background:

Patients often turn to online resources following the diagnosis of osteosarcoma. To be fully understood by the average American adult, the American Medical Association (AMA) and National Institutes of Health (NIH) recommend online health information to be written at a 6th grade level or lower. Previous analyses of osteosarcoma resources have not measured whether text is written such that readers can process key information (understandability) or identify available actions to take (actionability). The Patient Education Materials Assessment Tool (PEMAT) is a validated measurement of understandability and actionability.

Objective:

The purpose of this study was to evaluate osteosarcoma online resources utilizing measures of readability, understandability, and actionability.

Methods:

Using the search term “osteosarcoma”, two independent searches (Google.com) were performed and the top 50 results were collected. Websites were included if directed at providing patient education on osteosarcoma. Readability was quantified using validated algorithms: Flesh-Kincaid Grade Ease (FKGE), Flesch-Kincaid Grade-Level (FKGL). A higher FKGE score represents the material is easier to read. All other readability scores represent the US school grade level. Two independent PEMAT assessments were performed with independent scores assigned for both understandability and actionability. A PEMAT score of 70% or below is considered poorly understandable and/or poorly actionable. Statistical significance was defined as p≤0.05.

Results:

Of 53 unique websites, 37 websites (69.8%) met inclusion criteria. The mean FKGE was 40.8±13.6. The mean FKGL grade level was 12.0±2.4. No (0%) websites scored within the acceptable NIH/AHA recommended reading level. Overall, only 10.8% (n=4) and 2.7% (n=1) met the acceptable understandability and actionability threshold.

Conclusions:

Overall, osteosarcoma online patient educational materials scored poorly with respect to readability, understandability, and actionability. None of the online resources scored at the recommended reading level. Only four met the appropriate score to considered understandable by the general public. Future efforts should be made to improve online resources in order to support patient understanding.


 Citation

Please cite as:

Gulbrandsen T, Skalitzky MK, Shamrock AG, Gao B, Hasan O, Miller BJ

Web-Based Patient Educational Material on Osteosarcoma: Quantitative Assessment of Readability and Understandability

JMIR Cancer 2022;8(1):e25005

DOI: 10.2196/25005

PMID: 35323117

PMCID: 8990380

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.